D.E. Shaw & Co’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.04M | Sell |
644,542
-143,045
| -18% | -$1.34M | ﹤0.01% | 1328 |
|
|
2025
Q1 | $9.68M | Buy |
787,587
+603,470
| +328% | +$7.41M | 0.01% | 1018 |
|
|
2024
Q4 | $2.43M | Sell |
184,117
-168,241
| -48% | -$2.22M | ﹤0.01% | 1694 |
|
|
2024
Q3 | $6.78M | Buy |
352,358
+205,715
| +140% | +$3.96M | 0.01% | 1142 |
|
|
2024
Q2 | $3.01M | Buy |
146,643
+138,119
| +1,620% | +$2.84M | ﹤0.01% | 1527 |
|
|
2024
Q1 | $203K | Sell |
8,524
-33,441
| -80% | -$796K | ﹤0.01% | 2755 |
|
|
2023
Q4 | $907K | Sell |
41,965
-106,607
| -72% | -$2.3M | ﹤0.01% | 2115 |
|
|
2023
Q3 | $2.16M | Sell |
148,572
-24,447
| -14% | -$355K | ﹤0.01% | 1664 |
|
|
2023
Q2 | $3.62M | Buy |
173,019
+33,952
| +24% | +$711K | ﹤0.01% | 1420 |
|
|
2023
Q1 | $2.94M | Sell |
139,067
-21,368
| -13% | -$451K | ﹤0.01% | 1641 |
|
|
2022
Q4 | $4.08M | Buy |
160,435
+32,407
| +25% | +$825K | ﹤0.01% | 1579 |
|
|
2022
Q3 | $3.08M | Buy |
+128,028
| New | +$3.08M | ﹤0.01% | 1852 |
|
|
2022
Q1 | – | Sell |
-123,303
| Closed | -$2.7M | – | 4466 |
|
|
2021
Q4 | $2.7M | Sell |
123,303
-213,843
| -63% | -$4.68M | ﹤0.01% | 2191 |
|
|
2021
Q3 | $6.44M | Sell |
337,146
-73,321
| -18% | -$1.4M | 0.01% | 1302 |
|
|
2021
Q2 | $7.05M | Sell |
410,467
-163,471
| -28% | -$2.81M | 0.01% | 1254 |
|
|
2021
Q1 | $12.8M | Sell |
573,938
-81,069
| -12% | -$1.81M | 0.01% | 892 |
|
|
2020
Q4 | $14.6M | Buy |
655,007
+405,580
| +163% | +$9.02M | 0.01% | 817 |
|
|
2020
Q3 | $3.68M | Buy |
249,427
+148,836
| +148% | +$2.2M | ﹤0.01% | 1346 |
|
|
2020
Q2 | $1.49M | Buy |
100,591
+23,018
| +30% | +$341K | ﹤0.01% | 1748 |
|
|
2020
Q1 | $851K | Buy |
77,573
+13,840
| +22% | +$152K | ﹤0.01% | 1929 |
|
|
2019
Q4 | $559K | Buy |
+63,733
| New | +$559K | ﹤0.01% | 2153 |
|
|
2018
Q1 | – | Sell |
-23,063
| Closed | -$202K | – | 2648 |
|
|
2017
Q4 | $202K | Buy |
23,063
+7,433
| +48% | +$65.1K | ﹤0.01% | 2393 |
|
|
2017
Q3 | $183K | Buy |
+15,630
| New | +$183K | ﹤0.01% | 2359 |
|